Table 6 % CDR values after diffusion profile studies
From: Development of nanoemulsion of antiviral drug for brain targeting in the treatment of neuro-AIDS
Time (min) | B1 | B2 | B3 | B4 | B2 |
|---|---|---|---|---|---|
Diffusion study through egg membrane | Diffusion study through sheep nasal mucosa | ||||
15 | 3.11 ± 0.214 | 2.11 ± 1.13 | 4.34 ± 0.913 | 1.22 ± 0.753 | 4.34532 ± 0.14 |
30 | 4.27 ± 1.35 | 3.47 ± 0.87 | 5.82 ± 1.03 | 2.45 ± 0.434 | 5.78417 ± 0.25 |
45 | 9.55 ± 0.587 | 9.88 ± 0.741 | 10.34 ± 0.642 | 8.66 ± 1.23 | 10.2446 ± 0.15 |
60 | 17.34 ± 0.623 | 15.55 ± 0.61 | 20.66 ± 1.20 | 14.26 ± 0.946 | 20.4604 ± 0.11 |
90 | 40.98 ± 0.975 | 35.65 ± 1.22 | 47.34 ± 0.946 | 33.94 ± 0.846 | 46.9353 ± 0.16 |
120 | 57.82 ± 0.813 | 48.96 ± 1.34 | 61.62 ± 1.09 | 45.36 ± 1.115 | 60.7482 ± 0.11 |
150 | 60.77 ± 1.29 | 58.14 ± 0.974 | 67.26 ± 0.976 | 56.31 ± 0.643 | 65.7842 ± 0.09 |
180 | 70.42 ± 0.750 | 74.98 ± 1.06 | 71.96 ± 0.853 | 65.94 ± 1.054 | 75.9841 ± 0.14 |